Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Relationship between the risk of gastric cancer and adherence to the mediterranean diet according to different estimators. MCC—Spain Study

  • Álvarez Álvarez, Laura
  • Vitelli Storelli, Facundo Ezequiel
  • Rubín García, María
  • Aragonés, Nuria
  • Ardanaz, Eva
  • Castaño Vinyals, Gemma
  • Obón Santacana, Mireia
  • Dierssen Sotos, Trinidad
  • Salas Trejo, Dolores
  • Tardón, Adonina
  • Jiménez Moleon, José Juan
  • Alguacil, Juan
  • Chirlaque, María Dolores
  • Perez Gomez, Beatriz
  • Pollán, Marina
  • Kogevinas, Manolis
  • Martín Sánchez, Vicente
[EN]The aim was to assess the effect of adherence to the Mediterranean Diet, measured with five different indexes, on the risk of gastric cancer. Data come from the multicase-control study MCC—Spain, which included 354 gastric cancer cases and 3040 controls with data on diet. We used five indexes to evaluate adherence to the Mediterranean diet and assess the association between each pattern with the risk of gastric cancer, using multivariate logistic regression. The analyses were performed for the whole set of gastric cancer cases, by anatomical location (cardia and noncardia) and by histological type (intestinal and diffuse). According to the used index, a high adherence protects one from gastric cancer (between 48% (aOR = 0.52; CI 95% = 0.28–0.94) and 75% (aOR = 0.25; CI 95% = 0.12–0.52)), fromnon-cardia (between 48%(aOR = 0.52; CI 95% = 0.36–0.75) and 65% (aOR = 0.35; CI 95% = 0.23–0.52)), and from the intestinal type (between 41% (aOR = 0.59; CI 95% = 0.36–0.95) and 72% (aOR = 0.28; CI 95% = 0.16–0.50)), but not from the diffuse type. In conclusion, high adherence to a Mediterranean diet pattern is a protective factor for the risk of gastric cancer, with greater adherence leading to greater protection., SI, The study was partially funded by the “Accion Transversal del Cancer”, approved on the Spanish Ministry Council on 11 October 2007; by the Instituto de Salud Carlos III-FEDER (PI08/1770, PI08/0533, PI08/1359, PS09/00773-Cantabria, PS09/01286-León, PS09/01903-Valencia, PS09/02078- Huelva, PS09/01662-Granada, PI11/01403, PI11/01889-FEDER, PI11/00226, PI11/01810, PI11/02213, PI12/00488, PI12/00265, PI12/01270, PI12/00715, PI12/00150, PI14/01219, PI14/0613, PI15/00069, PI15/00914, PI15/01032, PI17CIII/00034); by the Fundación Marqués de Valdecilla (API 10/09); by the ICGC International Cancer Genome Consortium CLL (the ICGC CLL-Genome Project is funded by Spanish Ministerio de Economía y Competitividad (MINECO) through the Instituto de Salud Carlos III (ISCIII) and Red Temática de Investigación del Cáncer (RTICC) del ISCIII (RD12/0036/0036)); by the Junta de Castilla y León (LE22A10-2); by the Consejería de Salud of the Junta de Andalucía (PI-0571-2009, PI-0306-2011, salud201200057018tra); by the Conselleria de Sanitat of the Generalitat Valenciana (AP_061/10); by the Recercaixa (2010ACUP 00310); by the Regional Government of the Basque Country; by the Consejería de Sanidad de la Región de Murcia; by the European Commission grants FOOD-CT-2006-036224-HIWATE; by the Spanish Association Against Cancer (AECC) Scientific Foundation—grant GCTRA18022MORE; by the Catalan Government—Agency for Management of University and Research Grants (AGAUR) grants 2017SGR723 and 2014SGR850; by the Fundación Caja de Ahorros de Asturias; and by the University of Oviedo. ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya. M Obón-Santacana received a post-doctoral fellowship from the Spanish Association Against Cancer (AECC) Scientific Foundation. M Obón-Santacana is part of group 55 of CIBERESP and AGAUR 2017SGR723. M. R-G. is supported by the Ministry of Education of Spain (FPU17/06488).
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Lifetime Swimming Pool Attendance and Cancer Risk: Findings from the Multicase-Control Study in Spain (MCC-Spain)

  • Donat Vargas, Carolina
  • Vallbona Vistós, Miquel
  • Castaño Vinyals, Gemma
  • Moreno González, Víctor
  • Aragonés, Nuria
  • Boldo, Elena
  • Molina de la Torre, Antonio José
  • Gómez Acebo, Inés
  • Guevara, Marcela
  • Jiménez Zabala, Ana
  • Amiano, Pilar
  • Molina Barceló, Ana
  • Fernández Tardón, Guillermo
  • Chirlaque, María Dolores
  • Pollán, Marina
  • Kogevinas, Manolis
  • Villanueva, Cristina M.
[EN] Swimming in pools involves inhalation and skin absorption of potential carcinogenic disinfection byproducts (DBPs) as well as physical activity, which is protective for some cancer sites. We evaluated the association between lifetime pool attendance and the risk of breast, colorectal, and prostate cancer in a multicase-control study that recruited 4,941 hospital-based cancer cases (1,724 breast, 2,111 colorectal, 1,106 prostate) and 4,039 population-based controls in Spain (2008–2013). Lifetime swimming pool attendance in summer (as a surrogate of outdoor pools) and the rest of the year (as a surrogate of indoor pools), socio-demographics, and lifestyle were ascertained in face-to-face interviews. Cancer risk associated with pool attendance markers was estimated using linear mixed-effect models, adjusting for covariates with recruitment area as a random effect. Participants reporting lifetime pool attendance compared to those who did not showed lower odds of breast and colorectal cancer (approximately 5% lower risk). Swimming more than 10 times/month did not increase the protective association. For breast and colorectal cancer, only pool attendance outside the summer months was associated with a lower risk, whereas it was associated with increased prostate cancer risk. Findings suggest that lifetime swimming in pools may reduce breast cancer and colorectal cancer risk despite DBP exposure. These novel findings require replication, SI, The study was partially funded by the \u201CAccion Transversal del Cancer\u201D, approved by the Spanish Ministry Council on the 11th October 2007, by the Instituto de Salud Carlos III-FEDER (PI08/1770, PI08/0533, PI08/1359, PS09/00773, PS09/01286, PS09/01903, PS09/02078, PS09/01662, PI11/01889, PI11/00226, PI12/01270, PI12/00715, PI14/0613, PI15/00914, PI17CIII/00034), by the Fundacio\u0301n Marque\u0301s de Valdecilla (API 10/09), by the Conselleria de Sanitat of the Generalitat Valenciana (AP_061/10), by the European Commission grants FOOD-CT-2006-036224-HIWATE, by the Spanish Association Against Cancer (AECC) Scientific Foundation, by the Catalan Government-Agency for Management of University and Research Grants (AGAUR) grants 2017SGR723 and 2014SGR850, and by the Fundacio\u0301n Caja de Ahorros de Asturias and by the University of Oviedo. We acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/10.13039/501100011033 and support from the Generalitat de Catalunya through the CERCA Program